73.43
Overview
News
Price History
Option Chain
Financials
Why CTVA Down?
Discussions
Forecast
Dividend History
Corteva Inc stock is traded at $73.43, with a volume of 2.67M.
It is up +0.42% in the last 24 hours and up +0.26% over the past month.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
See More
Previous Close:
$73.12
Open:
$72.84
24h Volume:
2.67M
Relative Volume:
0.71
Market Cap:
$50.09B
Revenue:
$16.83B
Net Income/Loss:
$1.14B
P/E Ratio:
44.77
EPS:
1.64
Net Cash Flow:
$2.10B
1W Performance:
+0.52%
1M Performance:
+0.26%
6M Performance:
+14.81%
1Y Performance:
+32.83%
Corteva Inc Stock (CTVA) Company Profile
Name
Corteva Inc
Sector
Industry
Phone
(833) 267-8382
Address
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CTVA
Corteva Inc
|
73.43 | 49.88B | 16.83B | 1.14B | 2.10B | 1.64 |
![]()
NTR
Nutrien Ltd
|
60.09 | 29.39B | 25.68B | 527.00M | 839.00M | 1.07 |
![]()
CF
Cf Industries Holdings Inc
|
93.30 | 15.15B | 6.13B | 1.34B | 1.86B | 7.59 |
![]()
MOS
Mosaic Company
|
36.90 | 11.86B | 11.06B | 367.80M | 212.50M | 1.16 |
![]()
ICL
Icl Group Ltd
|
6.80 | 8.83B | 6.84B | 407.00M | 755.00M | 0.32 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-31-25 | Upgrade | Argus | Hold → Buy |
Mar-13-25 | Initiated | Goldman | Buy |
Oct-23-24 | Initiated | Citigroup | Buy |
Oct-16-24 | Upgrade | BofA Securities | Neutral → Buy |
Aug-07-24 | Downgrade | Argus | Buy → Hold |
Apr-12-24 | Downgrade | JP Morgan | Overweight → Neutral |
Mar-01-24 | Initiated | Wolfe Research | Outperform |
Feb-12-24 | Upgrade | Loop Capital | Hold → Buy |
Feb-02-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Nov-27-23 | Downgrade | Berenberg | Buy → Hold |
Nov-14-23 | Downgrade | Barclays | Overweight → Equal Weight |
Oct-20-23 | Upgrade | Oppenheimer | Perform → Outperform |
Sep-05-23 | Upgrade | UBS | Neutral → Buy |
Jul-25-23 | Downgrade | Redburn | Buy → Neutral |
Jun-28-23 | Initiated | Canaccord Genuity | Buy |
May-22-23 | Upgrade | Vertical Research | Hold → Buy |
Apr-06-23 | Initiated | Oppenheimer | Perform |
Jan-19-23 | Initiated | Wells Fargo | Overweight |
Jan-11-23 | Upgrade | BofA Securities | Underperform → Neutral |
Nov-16-22 | Downgrade | UBS | Buy → Neutral |
Nov-15-22 | Downgrade | Loop Capital | Buy → Hold |
Aug-08-22 | Upgrade | JP Morgan | Neutral → Overweight |
Aug-08-22 | Upgrade | ROTH Capital | Neutral → Buy |
Jul-14-22 | Initiated | Credit Suisse | Outperform |
Jun-01-22 | Initiated | Barclays | Overweight |
May-06-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-14-22 | Upgrade | Loop Capital | Hold → Buy |
Apr-14-22 | Downgrade | Vertical Research | Buy → Hold |
Jan-31-22 | Upgrade | Redburn | Neutral → Buy |
Oct-18-21 | Downgrade | Loop Capital | Buy → Hold |
Oct-13-21 | Initiated | Mizuho | Buy |
Oct-08-21 | Initiated | ROTH Capital | Buy |
Sep-01-21 | Initiated | Berenberg | Buy |
Aug-09-21 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
May-10-21 | Downgrade | BofA Securities | Buy → Underperform |
Apr-19-21 | Upgrade | Loop Capital | Hold → Buy |
Feb-05-21 | Upgrade | JP Morgan | Neutral → Overweight |
Feb-05-21 | Reiterated | Monness Crespi & Hardt | Sell |
Dec-18-20 | Downgrade | Susquehanna | Positive → Neutral |
Dec-14-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-10-20 | Upgrade | Argus | Hold → Buy |
Oct-19-20 | Upgrade | BofA Securities | Neutral → Buy |
Oct-19-20 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
Aug-11-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Aug-10-20 | Downgrade | BofA Securities | Buy → Neutral |
Jul-13-20 | Upgrade | BofA Securities | Underperform → Buy |
Jun-26-20 | Initiated | Cleveland Research | Neutral |
Jun-16-20 | Upgrade | Vertical Research | Hold → Buy |
Jun-08-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
May-11-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
Apr-17-20 | Downgrade | BofA/Merrill | Buy → Neutral |
Apr-17-20 | Upgrade | Loop Capital | Sell → Hold |
Apr-01-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Mar-31-20 | Upgrade | Susquehanna | Neutral → Positive |
Mar-26-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
Mar-19-20 | Upgrade | Edward Jones | Hold → Buy |
Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
Mar-10-20 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
View All
Corteva Inc Stock (CTVA) Latest News
Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings - simplywall.st
How strong is Corteva Inc. company’s balance sheetAchieve unparalleled market performance - jammulinksnews.com
What are the technical indicators suggesting about Corteva Inc.High-octane gains - jammulinksnews.com
What are Corteva Inc. company’s key revenue driversAchieve exceptional returns with expert guidance - jammulinksnews.com
Corteva unveils biological seed treatment - AgriNews
Corteva, Inc. (NYSE:CTVA) Is Largely Controlled by Institutional Shareholders Who Own 87% of the Company - 富途牛牛
How volatile is Corteva Inc. stock compared to the marketHigh-yield growth strategies - jammulinksnews.com
Is Corteva Inc. a growth stock or a value stockUncover the best stocks for explosive growth - jammulinksnews.com
Corteva's Quarterly Earnings Preview: What You Need to Know - MSN
Corteva Announces Dates for Second Quarter 2025 Earnings Release and Webcast - Discover 361
What analysts say about Corteva Inc. stockConsistently outstanding ROI - PrintWeekIndia
What drives Corteva Inc. stock priceAccelerated financial growth - PrintWeekIndia
Is Corteva Inc. stock overhyped or has real potentialOutstanding growth strategies - jammulinksnews.com
Corteva (NYSE:CTVA) Shareholders Will Want The ROCE Trajectory To Continue - Yahoo Finance
Corteva Inc. Stock Analysis and ForecastDynamic investment opportunities - Autocar Professional
Is Corteva Inc. a good long term investmentFree Popular Stock Recommendations - jammulinksnews.com
Corteva Sees Increased Price Target with Strong Buy Rating - AInvest
Corteva's (NYSE:CTVA) investors will be pleased with their splendid 172% return over the last five years - Yahoo Finance
3rd Circ. Won't Halt Corteva Pension Judgment For Appeal - Law360
Corteva, Inc.'s (NYSE:CTVA) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - 富途牛牛
Lobbying Update: $900,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed - Quiver Quantitative
Corteva (CTVA) Sees Increased Price Target with Strong Buy Ratin - GuruFocus
Corteva, Inc. (CTVA) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN
Corteva's Quarterly Earnings Preview: What You Need To Know - Barchart.com
Farm Hands on the Potomac: Modisett Kemp to lead government affairs at Corteva, Simpson assumes leadership of NCFC - Agri-Pulse
Lobbying Update: $60,000 of CORTEVA AGRISCIENCE lobbying was just disclosed - Quiver Quantitative
Fund Update: Ballentine Partners, LLC added 120,908 shares of CORTEVA ($CTVA) to their portfolio - Quiver Quantitative
Oppenheimer Adjusts Corteva Price Target to $87 From $75, Maintains Outperform Rating - MarketScreener
Mizuho Securities Adjusts Corteva Price Target to $85 From $80, Maintains Outperform Rating - MarketScreener
Corteva Inc Stock (CTVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):